Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jeffrey A Allen

Showing results (21-30 of 47) with videos related to

Pageof 5
Sort By:
Neuromuscular Disorders : NMD|January 4, 2011
Reversible demyelinating neuropathy associated with renal cell carcinomaJeffrey A Allen, Ximing J Yang, Robert L Sufit
JAMA Neurology|April 28, 2020
Monitoring Clinical Course and Treatment Response in Chronic Inflammatory Demyelinating Polyneuropathy During Routine Care: A Review of Clinical and Laboratory Assessment MeasuresJeffrey A Allen, Ingemar S J Merkies, Richard A Lewis
Patient Preference and Adherence|April 28, 2021
Patient Preferences for Subcutaneous versus Intravenous Administration of Treatment for Chronic Immune System Disorders: A Systematic ReviewPaul M Overton, Natalie Shalet, Fabian Somers, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 24, 2013
Phase 1/2 open-label dose-escalation study of plasmid DNA expressing two isoforms of hepatocyte growth factor in patients with painful diabetic peripheral neuropathySenda Ajroud-Driss, Mark Christiansen, Jeffrey A Allen, et al.
Journal of Clinical Neuromuscular Disease|March 16, 2013
Distal acquired demyelinating symmetric neuropathy after vaccinationKarissa L Gable, Zahra Afshari, Robert L Sufit, et al.
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|April 9, 2008
Muscle atrophy associated with multiple sclerosis: a benign condition or the onset of amyotrophic lateral sclerosis?Jeffrey A Allen, Robert Stein, Richard A Baker, et al.
Complementary Therapies in Clinical Practice|July 12, 2005
A pilot study of therapeutic massage for people with Parkinson's disease: the added value of user involvementCharlotte Paterson, Jeffrey A Allen, Margaret Browning, et al.
Journal of the Peripheral Nervous System : JPNS|March 25, 2018
Individualized immunoglobulin therapy in chronic immune-mediated peripheral neuropathiesJeffrey A Allen, Melvin Berger, Luis Querol, et al.
Journal of the Peripheral Nervous System : JPNS|April 27, 2018
Risk factors for the development of paclitaxel-induced neuropathy in breast cancer patientsJetter Robertson, Jeffrey Raizer, James S Hodges, et al.
Journal of the Peripheral Nervous System : JPNS|October 7, 2025
Insight in the Unmet Needs Encountered During the Management of Chronic Inflammatory Demyelinating PolyradiculoneuropathyJeffrey A Allen, Helmar C Lehmann, Eduardo Nobile-Orazio, et al.
Pageof 5

Showing results (21-30 of 47) with videos related to

Sort By:
Pageof 5
Neuromuscular Disorders : NMD|January 4, 2011
Reversible demyelinating neuropathy associated with renal cell carcinomaJeffrey A Allen, Ximing J Yang, Robert L Sufit
JAMA Neurology|April 28, 2020
Monitoring Clinical Course and Treatment Response in Chronic Inflammatory Demyelinating Polyneuropathy During Routine Care: A Review of Clinical and Laboratory Assessment MeasuresJeffrey A Allen, Ingemar S J Merkies, Richard A Lewis
Patient Preference and Adherence|April 28, 2021
Patient Preferences for Subcutaneous versus Intravenous Administration of Treatment for Chronic Immune System Disorders: A Systematic ReviewPaul M Overton, Natalie Shalet, Fabian Somers, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 24, 2013
Phase 1/2 open-label dose-escalation study of plasmid DNA expressing two isoforms of hepatocyte growth factor in patients with painful diabetic peripheral neuropathySenda Ajroud-Driss, Mark Christiansen, Jeffrey A Allen, et al.
Journal of Clinical Neuromuscular Disease|March 16, 2013
Distal acquired demyelinating symmetric neuropathy after vaccinationKarissa L Gable, Zahra Afshari, Robert L Sufit, et al.
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|April 9, 2008
Muscle atrophy associated with multiple sclerosis: a benign condition or the onset of amyotrophic lateral sclerosis?Jeffrey A Allen, Robert Stein, Richard A Baker, et al.
Complementary Therapies in Clinical Practice|July 12, 2005
A pilot study of therapeutic massage for people with Parkinson's disease: the added value of user involvementCharlotte Paterson, Jeffrey A Allen, Margaret Browning, et al.
Journal of the Peripheral Nervous System : JPNS|March 25, 2018
Individualized immunoglobulin therapy in chronic immune-mediated peripheral neuropathiesJeffrey A Allen, Melvin Berger, Luis Querol, et al.
Journal of the Peripheral Nervous System : JPNS|April 27, 2018
Risk factors for the development of paclitaxel-induced neuropathy in breast cancer patientsJetter Robertson, Jeffrey Raizer, James S Hodges, et al.
Journal of the Peripheral Nervous System : JPNS|October 7, 2025
Insight in the Unmet Needs Encountered During the Management of Chronic Inflammatory Demyelinating PolyradiculoneuropathyJeffrey A Allen, Helmar C Lehmann, Eduardo Nobile-Orazio, et al.
Pageof 5